Administration of adjuvant oxaliplatin to patients with stage III colon cancer is affected by age and hospital

Acta Oncol. 2014 Jul;53(7):975-80. doi: 10.3109/0284186X.2013.878470. Epub 2014 Jan 21.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Antineoplastic Agents / administration & dosage*
  • Chemotherapy, Adjuvant / statistics & numerical data*
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / pathology
  • Colonic Neoplasms / surgery
  • Female
  • Hospitals / statistics & numerical data
  • Humans
  • Male
  • Netherlands / epidemiology
  • Odds Ratio
  • Organoplatinum Compounds / administration & dosage*
  • Oxaliplatin

Substances

  • Antineoplastic Agents
  • Organoplatinum Compounds
  • Oxaliplatin